Indianapolis Zantac Attorneys

FIGHTING FOR YOU WHEN THE STAKES ARE HIGHEST

Zantac, a popular over-the-counter and prescription-strength heartburn medication has been recalled due to a potential carcinogenic contamination. The drug, sold generically as ranitidine, tested positive for unsafe levels of a chemical called NDMA, which is classified as a probable carcinogen (a substance that could cause cancer). The consumption of high levels of NDMA can result in severe health problems, including the development of several deadly cancers, which is why those affected need to take action immediately to protect their health and preserve their legal rights.

If you or someone you love developed cancer after taking Zantac or a generic form of ranitidine, our team at Wagner Reese is here to help.

Let Us Help You

Fill out the form below, and our team will contact you to schedule a free consultation.








    Why Choose Our Firm?

    At Wagner Reese, we’re passionate about fighting for the rights of the wrongfully injured and we have the experience and skill you need, however complex or difficult your case. Several of our attorneys have received prestigious awards and recognitions from organizations like Best Lawyers, Super Lawyers, The National Trial Lawyers, and the Multi-Million Dollar Advocates Forum, so you never have to worry about whether or not you’re working with an experienced, knowledgeable team. With more than 150 years of collective practice and over $300 million recovered, we know we can provide you with the representation you need and deserve.

    Call (888) 204-8440 today to schedule a free consultation with our Indianapolis-based Zantac injury lawyers.

    About Zantac

    The U.S. Food and Drug Administration (FDA) first approved Glaxo Holdings Ltd.’s sale of Zantac in 1983 after it had already been approved in more than 30 other countries. Zantac’s popularity grew so quickly that by 1988, it became one of the first drugs to hit $1 billion in annual sales. Generic forms of Zantac, called ranitidine, launched in the 1990s, and the drug was distributed in its over-the-counter form in the early 2000s.

    Just last year, a Connecticut lab, Valisure, conducted an NDMA study and tested a wide variety of drugs for any alarming amounts of the cancer-causing material. One of the drugs tested in this study was Zantac. According to the results of this study, the body converts the materials in the drug in such a way that increases the levels of NDMA in the body. As a result, the study indicated, the amount of NDMA found in Zantac was more than 400 times greater than what the FDA deems an “acceptable” amount for the public to consume.

    FDA Warnings: Zantac Use

    In September of 2019, the FDA sent out a warning to the public, stating, “some ranitidine medicines, including some products commonly known as the brand-name drug Zantac, contain a nitrosamine impurity called N-nitrosodimethylamine (NDMA).” Although the warning only asked for a voluntary recall, several drug stores, including CVS, have since removed all ranitidine products, including Zantac, from their shelves.

    Shortly thereafter, on October 18, 2019, Sanofi, the pharmaceutical company that currently owns Zantac, issued a voluntary recall of all Zantac products in the United States and Canada.

    How is Zantac Dangerous?

    The NDMA contaminant found in Zantac and other ranitidine medicines is a probable carcinogen, which means regular or substantial exposure to NDMA can result in the development of cancer. Because Zantac was used to treat ulcers as a prescription medication, many patients were exposed to high dosages of the medication on an ongoing basis, and, as a result, could have consumed hazardous levels of NDMA unknowingly. Likewise, anyone who used Zantac or a generic form of ranitidine for over-the-counter heartburn relief regularly could have been exposed to dangerous levels of carcinogenic material.

    NDMA-related Zantac exposure can result in the following side effects:

    • Bladder cancer
    • Colorectal cancer
    • Kidney cancer
    • Liver cancer
    • Pancreatic cancer
    • Stomach cancer
    • Prostate cancer

    If you or someone you love developed any of the above-listed cancers after taking Zantac or its generic form, make sure you seek legal counsel immediately. You may be entitled to compensation from the liable party, which could help pay for your medical bills, loss of wages, pain and suffering, and more. We understand that a cancer diagnosis is an impossibly difficult battle, which is why our firm is here to provide you with the steadfast legal support you deserve at a time when you need it most.

    Do you have a case? Our team at Wagner Reese is prepared to discuss your Indianapolis Zantac injury case and help you find a viable legal solution. We have ample experience with a variety of dangerous drug lawsuits, and we aren’t afraid to go up against big pharmaceutical companies. We firmly believe the negligent party should be held responsible for the harm they’ve caused, and we want to use our legal knowledge to exercise your legal rights.

    Contact Wagner Reese today to discuss your case with an Indianapolis Zantac injury attorney.

    logo

    Why Choose Wagner Reese

    OVER $300 MILLION RECOVERED

    EVENING & WEEKEND APPOINTMENTS AVAILABLE

    YOU DO NOT PAY UNTIL WE WIN